ANNOUNCEMENT {#s1}
============

Bacterial strains belonging to the family *Eggerthellaceae* are members of the human gut microbiome ([@B1]). Many strains that are able to metabolize secondary plant compounds, such as digoxin ([@B2]), daidzein ([@B3]), ellagic acid ([@B4]), and pyrrolizidine alkaloids ([@B5]), have been investigated. The type strain of Adlercreutzia equolifaciens subsp. *equolifaciens* is capable of metabolizing daidzein and resveratrol to equol and dihydroresveratrol, respectively ([@B3], [@B6]). Strains of the genus *Gordonibacter* show the ability to transform ellagic acid into various urolithin derivatives ([@B4]). Strains of Eggerthella lenta have been reported to metabolize resveratrol and digoxin to dihydroresveratrol and dihydrodigoxin, respectively ([@B2], [@B7]). Bisanz et al. ([@B8]) analyzed 24 different strains of E. lenta and published a variable pan-genome, which underlines the diverse biochemical potential of E. lenta strains ([@B8]).

In this study, we announce the annotated draft genome sequences of 13 *Eggerthellaceae* strains isolated from fecal samples from two healthy (i.e., not suffering from chronic or acute disease) adult human volunteers in Karlsruhe, Germany, namely, Adlercreutzia equolifaciens ResAG-91, Eggerthella lenta MRI-F 36, MRI-F 37, MRI-F 40, ResAG-49, ResAG-88, ResAG-121, and ResAG-145, and Gordonibacter urolithinfaciens ResAG-5, ResAG-26, ResAG-43, ResAG-50, and ResAG-59.

MRI-F and ResAG strains were isolated at 37°C under strictly anaerobic conditions (N~2~-CO~2~-H~2~ \[80:10:10\]) in an A45 anaerobic workstation (Don Whitley Scientific). For ResAG strains, isolation was performed as described previously ([@B9]). In brief, 7.5 g of a fecal sample was diluted with N~2~-CO~2~ (80:20)-flushed brain heart infusion (BHI) medium (Merck) supplemented with 0.5% yeast extract, 0.05% [l]{.smallcaps}-cysteine monohydrochloride (Roth), 1 mg ml^−1^ resazurin sodium salt, 2.5 mg liter^−1^ heme solution, and 2 μg ml^−1^ vitamin K~1~ solution (Sigma-Aldrich). After incubation for 10 min at 37°C at 120 rpm, the sample was centrifuged for 10 min at 300 × *g*. The supernatant was used as a fecal suspension. A Hungate tube containing 9 ml BHI medium supplemented with ampicillin (1 μg ml^−1^), colistin (5 μg ml^−1^), chloramphenicol (5 μg ml^−1^), cholic acid (18 μg ml^−1^), and *trans*-resveratrol (80 μM) was inoculated with 1 ml fresh fecal suspension. For isolation of MRI-F strains, the preparation of the fecal suspension was the same as described above except BHI medium without supplements was used for preparation of the fecal suspension. Pure cultures were obtained from colonies from different agar plates ([Table 1](#tab1){ref-type="table"}).

###### 

Isolation medium, accession numbers, assembly metrics, and annotated features of the isolated and sequenced strains

  Bacterial species and strain                Isolation medium[^*a*^](#ngtab1.1){ref-type="table-fn"}   Estimated insert size (bp)   Total no. of generated reads   No. of trimmed reads   Trimmed reads mapped against respective contigs (%)   Genome size (bp)   No. of contigs (avg coverage \[×\])   *N*~50~ (bp)   Total no. of genes   G+C content (%)   GenBank accession no. for:                                                                                                      
  ------------------------------------------- --------------------------------------------------------- ---------------------------- ------------------------------ ---------------------- ----------------------------------------------------- ------------------ ------------------------------------- -------------- -------------------- ----------------- ------------------------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------------------
  *Adlercreutzia equolifaciens* ResAG-91      BHI                                                       273.686                      985,811                        977,851                99.25                                                 2,798,076          74 (94.93)                            107,842        2,394                63.31             [WPOO00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOO00000000)   [SRX7372034](https://www.ncbi.nlm.nih.gov/sra/SRX7372034)   [MH553318](https://www.ncbi.nlm.nih.gov/nuccore/MH553318)
  *Eggerthella lenta* MRI-F 36                DSMZ medium 339                                           246.491                      1,435,469                      1,423,441              99.51                                                 3,299,594          52 (105.81)                           129,153        2,869                64.18             [WPOJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOJ00000000)   [SRX7372042](https://www.ncbi.nlm.nih.gov/sra/SRX7372042)   [MH741250](https://www.ncbi.nlm.nih.gov/nuccore/MH741250)
  *Eggerthella lenta* MRI-F 37                DSMZ medium 339                                           261.130                      1,154,148                      1,142,818              99.30                                                 3,296,275          54 (89.90)                            98,732         2,870                64.17             [WPOI00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOI00000000)   [SRX7372043](https://www.ncbi.nlm.nih.gov/sra/SRX7372043)   [MH741251](https://www.ncbi.nlm.nih.gov/nuccore/MH741251)
  *Eggerthella lenta* MRI-F 40                DSMZ medium 209                                           266.125                      1,404,393                      1,394,064              99.57                                                 3,300,040          51 (111.94)                           141,895        2,871                64.17             [WPOH00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOH00000000)   [SRX7372044](https://www.ncbi.nlm.nih.gov/sra/SRX7372044)   [MH741252](https://www.ncbi.nlm.nih.gov/nuccore/MH741252)
  *Eggerthella lenta* ResAG-49                BHI                                                       272.720                      1,418,094                      1,407,300              99.55                                                 3,401,533          75 (112.32)                           104,054        2,974                64.02             [WPON00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPON00000000)   [SRX7372035](https://www.ncbi.nlm.nih.gov/sra/SRX7372035)   [MN326807](https://www.ncbi.nlm.nih.gov/nuccore/MN326807)
  *Eggerthella lenta* ResAG-88                BHI                                                       250.974                      1,142,425                      1,132,812              99.49                                                 3,472,506          81 (81.46)                            120,561        3,005                64.02             [WPOM00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOM00000000)   [SRX7372039](https://www.ncbi.nlm.nih.gov/sra/SRX7372039)   [MH553319](https://www.ncbi.nlm.nih.gov/nuccore/MH553319)
  *Eggerthella lenta* ResAG-121               BHI                                                       244.812                      939,424                        934,970                99.29                                                 3,485,223          147 (65.21)                           68,051         3,049                64.01             [WPOL00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOL00000000)   [SRX7372040](https://www.ncbi.nlm.nih.gov/sra/SRX7372040)   [MN326808](https://www.ncbi.nlm.nih.gov/nuccore/MN326808)
  *Eggerthella lenta* ResAG-145               BHI                                                       246.178                      1,070,253                      1,061,803              99.36                                                 3,501,112          154 (74.18)                           70,468         3,081                64.01             [WPOK00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOK00000000)   [SRX7372041](https://www.ncbi.nlm.nih.gov/sra/SRX7372041)   [MH553320](https://www.ncbi.nlm.nih.gov/nuccore/MH553320)
  *Gordonibacter urolithinfaciens* ResAG-5    BHI                                                       273.836                      1,200,885                      1,191,875              99.20                                                 3,654,461          148 (88.60)                           63,214         3,271                65.84             [WPOG00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOG00000000)   [SRX7372045](https://www.ncbi.nlm.nih.gov/sra/SRX7372045)   [MN326811](https://www.ncbi.nlm.nih.gov/nuccore/MN326811)
  *Gordonibacter urolithinfaciens* ResAG-26   BHI                                                       292.846                      1,308,806                      1,305,933              99.59                                                 3,609,950          92 (105.51)                           92,475         3,205                65.91             [WPOF00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOF00000000)   [SRX7372046](https://www.ncbi.nlm.nih.gov/sra/SRX7372046)   [MN326812](https://www.ncbi.nlm.nih.gov/nuccore/MN326812)
  *Gordonibacter urolithinfaciens* ResAG-43   BHI                                                       307.341                      1,022,809                      1,020,471              99.59                                                 3,663,595          82 (85.26)                            86,434         3,253                65.88             [WPOE00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOE00000000)   [SRX7372036](https://www.ncbi.nlm.nih.gov/sra/SRX7372036)   [MH553321](https://www.ncbi.nlm.nih.gov/nuccore/MH553321)
  *Gordonibacter urolithinfaciens* ResAG-50   BHI                                                       282.045                      960,936                        957,184                99.31                                                 3,610,667          117 (74.25)                           64,270         3,212                65.92             [WPOD00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOD00000000)   [SRX7372037](https://www.ncbi.nlm.nih.gov/sra/SRX7372037)   [MN326813](https://www.ncbi.nlm.nih.gov/nuccore/MN326813)
  *Gordonibacter urolithinfaciens* ResAG-59   BHI                                                       284.838                      1,256,789                      1,253,103              99.62                                                 3,664,069          77 (97.04)                            98,836         3,250                65.88             [WPOC00000000](https://www.ncbi.nlm.nih.gov/nuccore/WPOC00000000)   [SRX7372038](https://www.ncbi.nlm.nih.gov/sra/SRX7372038)   [MN326814](https://www.ncbi.nlm.nih.gov/nuccore/MN326814)
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DSMZ medium 339, Wilkins-Chalgren anaerobe broth; DSMZ medium 209 (Eubacterium lentum medium), chopped meat medium supplemented with 0.5% arginine.

Strains were cultured and genomic DNA was isolated as described previously ([@B9][@B10][@B12]). Briefly, strains were cultivated for 2 days at 37°C, under anaerobic conditions, in N~2~-CO~2~ (80:20)-flushed BHI broth. DNA was extracted using a blood and tissue kit (Qiagen). DNA was quantified with the double-stranded DNA (dsDNA) high-sensitivity (HS) assay kit on a Qubit version 2.0 fluorometer (Thermo Fischer Scientific) and was adjusted to a concentration of 10 ng μl^−1^ or 0.2 ng μl^−1^ for 16S rRNA gene sequencing or whole-genome shotgun (WGS) sequencing, respectively.

Initial molecular identification of the isolated strains by 16S rRNA gene sequencing was performed as described previously ([@B9]). The 16S rRNA gene sequences were subjected to a BLASTn search ([@B13]) and have been deposited in DDBJ/ENA/GenBank ([Table 1](#tab1){ref-type="table"}). Species identification was performed using BioNumerics software (version 7.6; Applied Maths) with a 98.7% 16S rRNA gene sequence identity threshold, in comparison with related type strains ([@B14]).

The genome sequencing library was constructed as described previously ([@B12]) using a Nextera XT DNA library preparation kit and a Nextera XT index kit (Illumina). WGS sequencing was performed with an Illumina MiSeq benchtop sequencer using a 500-cycle version 2 kit (read length, 2 × 250 bp). For each strain, the total number of generated reads is listed in [Table 1](#tab1){ref-type="table"}. Data processing was performed as described previously ([@B10][@B11][@B12]). Default parameters were used for all software unless otherwise specified. Sequence reads were quality trimmed using Trimmomatic version 0.39 ([@B15]) and assembled using SPAdes version 3.13.1 in the careful mode ([@B16], [@B17]). The estimated insert size for each published sequence obtained in this study is listed in [Table 1](#tab1){ref-type="table"}. Adequate trimming was verified by mapping the adapter sequences to the assembled contigs using Bowtie 2 version 2.3.3.1 ([@B18]). To eliminate sequence contamination, the contigs were aligned to the genome of coliphage phi-X174 (GenBank accession number [NC_001422](https://www.ncbi.nlm.nih.gov/nuccore/NC_001422)) using a BLASTn search ([@B13]). All contigs of \<500 bp were manually excluded, and renaming of contigs was done by Awk ([@B19]). To calculate the genome coverage for each strain, trimmed reads were mapped against the remaining contigs by Bowtie 2 ([Table 1](#tab1){ref-type="table"}). Draft genome sequences were annotated using the automated NCBI Prokaryotic Genome Annotation Pipeline ([@B20]). The assembly metrics and annotated features of all the strains are given in [Table 1](#tab1){ref-type="table"}.

Data availability. {#s1.1}
------------------

The WGS project, including raw reads for Adlercreutzia equolifaciens ResAG-91, E. lenta MRI-F 36, MRI-F 37, MRI-F 40, ResAG-49, ResAG-88, ResAG-121, and ResAG-145, and Gordonibacter urolithinfaciens ResAG-5, ResAG-26, ResAG-43, ResAG-50, and ResAG-59, has been deposited in DDBJ/ENA/GenBank under BioProject accession number [PRJNA591748](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA591748). The versions described in this publication are the first versions and are listed in [Table 1](#tab1){ref-type="table"}.
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